Make a donation Start a fundraiser
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
Brain Cancer

Brain Cancer

The role of interleukin-6-STAT3 signalling in glioblastoma

[…]

Read More… from The role of interleukin-6-STAT3 signalling in glioblastoma

The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells

[…]

Read More… from The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells

MicroRNA as potential biomarkers in Glioblastoma

[…]

Read More… from MicroRNA as potential biomarkers in Glioblastoma

Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib

[…]

Read More… from Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib

The emergent role of exosomes in glioma

[…]

Read More… from The emergent role of exosomes in glioma

Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide

[…]

Read More… from Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide

A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker

[…]

Read More… from A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker

Peripheral biomarkers in glioblastoma patients—is it all just HOTAIR?

[…]

Read More… from Peripheral biomarkers in glioblastoma patients—is it all just HOTAIR?

Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs

[…]

Read More… from Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs

Using bioluminescence imaging in glioma research

[…]

Read More… from Using bioluminescence imaging in glioma research

Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance

[…]

Read More… from Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance

Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

[…]

Read More… from Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

Serum microRNA is a biomarker for post-operative monitoring in glioma

[…]

Read More… from Serum microRNA is a biomarker for post-operative monitoring in glioma

Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma

[…]

Read More… from Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma

The Signaling Networks of TIM-3, TGF-β and STING in Glioblastoma

[…]

Read More… from The Signaling Networks of TIM-3, TGF-β and STING in Glioblastoma

Growth Suppression of Intracranial Xenografted Glioblastomas Overexpressing Mutant Epidermal Growth Factor Receptors by Systemic Administration of Monoclonal Antibody (mAb) 806, a Novel Monoclonal Antibody Directed to the Receptor

[…]

Read More… from Growth Suppression of Intracranial Xenografted Glioblastomas Overexpressing Mutant Epidermal Growth Factor Receptors by Systemic Administration of Monoclonal Antibody (mAb) 806, a Novel Monoclonal Antibody Directed to the Receptor

Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment

[…]

Read More… from Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment

Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation

[…]

Read More… from Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation

Mouse models of glioma

[…]

Read More… from Mouse models of glioma

The Role of TIM-3 in Glioblastoma Progression

[…]

Read More… from The Role of TIM-3 in Glioblastoma Progression

Metabolic Plasticity of Glioblastoma Cells in Response to DHODH Inhibitor BAY2402234 Treatment

[…]

Read More… from Metabolic Plasticity of Glioblastoma Cells in Response to DHODH Inhibitor BAY2402234 Treatment

Systemic brain dissemination of glioblastoma requires transdifferentiation into endothelial-like cells via TGF-β-ALK1-Smad1/5 signaling

[…]

Read More… from Systemic brain dissemination of glioblastoma requires transdifferentiation into endothelial-like cells via TGF-β-ALK1-Smad1/5 signaling

Correlation of Galectin Family Expression with Glioblastoma Progression and Survival

[…]

Read More… from Correlation of Galectin Family Expression with Glioblastoma Progression and Survival

A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection

[…]

Read More… from A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection

The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients

[…]

Read More… from The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients

hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560

[…]

Read More… from hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560

The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis.

[…]

Read More… from The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis.

Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression

[…]

Read More… from Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism

[…]

Read More… from EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism

Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion

[…]

Read More… from Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion

Transforming growth factor-beta (TGF-beta) and brain tumours

[…]

Read More… from Transforming growth factor-beta (TGF-beta) and brain tumours

The EGFRvIII variant in glioblastoma multiforme

[…]

Read More… from The EGFRvIII variant in glioblastoma multiforme

The role of Stat3 in glioblastoma multiforme

[…]

Read More… from The role of Stat3 in glioblastoma multiforme

Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme

[…]

Read More… from Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme

  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us

Fundraisers

News & media

  • Irene’s memory to make a difference to research.
  • Creswick Community Bank
  • Skin cell breakthrough could lead to new treatments.
  • New finding from Breast cancer group.

Contact

admin@fecri.org.au



Phone

03 5331 3101

Location

Ballarat Technology Park
- Central Suite 23,
106-110 Lydiard St Sth
Ballarat Vic 3350

Postal

PO Box 549,
Ballarat VIC 3350

All material © Fiona Elsey Cancer Research Institute.

Site by
Pepper Brandmanagers